Lung cancer survival better in womenNovember 02, 2005Untreated, women with lung cancer live longer than men Women with lung cancer are living longer than men, even when the disease is untreated. A new study presented at CHEST 2005, the 71st annual international scientific assembly of the American College of Chest Physicians (ACCP), found that in patients receiving treatment for lung cancer, women had significantly better survival rates than men. However, in untreated patients, women also had a 21 percent decreased risk of death as compared with men, leading researchers to believe lung cancer in women has a different biologic behavior and natural history than in men. "In patients with lung cancer receiving treatment, women have shown a better response to therapy, resulting in better survival rates," said Juan Wisnivesky, MD, MPH, FCCP, Mount Sinai School of Medicine, New York, NY. "Yet, new data suggest that even in untreated patients, women with lung cancer still live longer than men, despite the presence of other medical conditions or gender differences in life expectancy. This suggests that the progression of lung cancer has a biological basis, with the disease being more aggressive in men than women."
Researchers from Mount Sinai School of Medicine reviewed 18,967 cases of stage I and II non-small cell lung cancer diagnosed between 1991 and 1999 from the Surveillance, Epidemiology, and End Results registry linked to Medicare records. Patients were grouped into three categories according to treatment received: surgery, radiation or chemotherapy, and untreated cases. After adjusting for comorbidities and general life expectancy, researchers found that women in the three groups had significantly better cancer specific, overall, and relative survival than men. In treated patients, lung cancer specific 5-year survival for women was 54 percent compared with 40 percent for men and women had a 30 percent decreased risk of death compared with men. Among untreated patients, women had a 21 percent decreased risk of lung cancer deaths after adjusting for differences in age, race, socioeconomic status, access to care, and cancer histology. Researchers also found that women lived longer than men after controlling for age, race, disease stage at diagnosis, histology, median income, geographic area, access to care, and type of treatment. "It is clear that gender plays a role in the survival rate of men and women," said W. Michael Alberts, MD, FCCP, President of the American College of Chest Physicians. "Physicians caring for patients with lung cancer should consider the inherent progression of lung cancer among men and women when deciding on a patient's course of treatment." American College of Chest Physicians | |||||||||||||||||||||
|
Related Lung Cancer News Articles African-Americans have unique lung cancer risks from chronic obstructive pulmonary disease Scientists at the M.D. Anderson Cancer Center have developed a risk prediction assessment for lung cancer specifically for African Americans that suggests a greater risk from chronic obstructive pulmonary disease (COPD). Breaking the 'mucus barrier' with a new drug delivery system Chemical engineers from Johns Hopkins University have broken the "mucus barrier," engineering the first drug-delivery particles capable of passing through human mucus - regarded by many as nearly impenetrable - and carrying medication that could treat a range of diseases. Those conditions include lung cancer, cervical cancer and cystic fibrosis, the research noted in a presentation scheduled for the 236th National Meeting of the American Chemical Society. Newly detected air pollutant mimics damaging effects of cigarette smoke A previously unrecognized group of air pollutants could have effects remarkably similar to harmful substances found in tobacco smoke, Louisiana scientists are reporting in a study scheduled for presentation today at the 236th National Meeting of the American Chemical Society. Targeted radiation therapy can control limited cancer spread Precisely targeted radiation therapy can eradicate all evidence of disease in selected patients with cancer that has spread to only a few sites, suggests the first published report from an ongoing clinical trial. Experimental chemotherapy regimen shows promise in treating advanced lung cancer A combination of chemotherapy agents that have been tested in other tumor types appears to be a promising alternative to standard treatment for advanced non-small cell lung cancer, according to a report in the August 15 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research. If your first cigarette gave you a buzz and you now smoke, a gene may be to blame Anyone who has ever tried smoking probably remembers that first cigarette vividly. For some, it brought a wave of nausea or a nasty coughing fit. For others, those first puffs also came with a rush of pleasure or "buzz." Gene panel predicts lung cancer survival, study finds Researchers from four leading cancer centers have confirmed that an analysis involving a panel of genes can be used to predict which lung cancer patients will have the worst survival. The finding could one day lead to a test that would help determine who needs more aggressive treatment. Vitamin A pushes breast cancer to form blood vessel cells Researchers at Georgetown University Medical Center have discovered that vitamin A, when applied to breast cancer cells, turns on genes that can push stem cells embedded in a tumor to morph into endothelial cells. These cells can then build blood vessels to link up to the body's blood supply, promoting further tumor growth. Patients unaware of link between smoking and bladder cancer Even though cigarette smoking accounts for up to half of all bladder cancer cases, few people are aware of the connection - including more than three-quarters of patients who have bladder cancer. New oral angiogenesis inhibitor offers potential nontoxic therapy for a wide range of cancers The first oral, broad-spectrum angiogenesis inhibitor, specially formulated through nanotechnology, shows promising anticancer results in mice, report researchers from Children's Hospital Boston. More Lung Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||